Weight Management Services
A Contract Award Notice
by NHS NOTTINGHAM AND NOTTINGHAMSHIRE INTEGRATED CARE BOARD
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- not specified
- Value
- £206K
- Sector
- HEALTH
- Published
- 17 Jul 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
Nottingham:
1 buyer
1 supplier
- Nottingham City General Practice Alliance Nottingham
Description
Prescribing of tirzepatide (Mounjaro®) within Primary Care for weight management following face-to- face assessment and on-going management through reviews
Total Quantity or Scope
Description of the services to be provided: Prescribing of tirzepatide (Mounjaro®) within Primary Care for weight management following face-to- face assessment and on-going management through reviews This notice is confirmation of an award having been made due to an urgent circumstance . The lifetime value of the contract is £206,400 The dates between which the contract provides for the service are 1 July 2025 to 30 June 2026.
Award Detail
1 | Nottingham City General Practice Alliance (Nottingham)
|
Award Criteria
To address immediate risks to safety and quality of care | 100 |
Value | 0 |
CPV Codes
- 85100000 - Health services
Legal Justification
This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** This contract has been awarded under the urgent circumstances provision of the Provider Selection Regime (PSR). This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. The award was made under an urgent circumstance as a result of the NICE publication of TA1026. As the decision has been made under urgent circumstances it will be limited to 12 months. The decision was made by the Chief Executive in line with the ICB's Scheme of Reservation and Delegation. No conflicts of interest were identified.
Reference
- ocds-h6vhtk-056102
- FTS 040849-2025